Survival after Lung Volume Reduction in Chronic Obstructive Pulmonary Disease
Top Cited Papers
- 1 September 2007
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 176 (5) , 454-459
- https://doi.org/10.1164/rccm.200612-1772oc
Abstract
Rationale: COPD is associated with reduced life expectancy. Objectives: To determine the association between small airway pathology and long-term survival after lung volume reduction in chronic obstructive pulmonary disease (COPD) and the effect of corticosteroids on this pathology. Methods: Patients with severe (GOLD-3) and very severe (GOLD-4) COPD (n = 101) were studied after lung volume reduction surgery. Respiratory symptoms, quality of life, pulmonary function, exercise tolerance, chest radiology, and corticosteroid treatment status were assessed preoperatively. The severity of luminal occlusion, wall thickening, and the presence of small airways containing lymphoid follicles were determined in resected lung tissue. Kaplan-Meier survival analysis and Cox proportional hazards models were used to determine the relationship between survival and small airway pathology. The effect of corticosteroids on this pathology was assessed by comparing treated and untreated groups. Measurements and Main Results: The quartile of subjects with the greatest luminal occlusion, adjusted for covariates, died earlier than subjects who had the least occlusion (hazard ratio, 3.28; 95% confidence interval, 1.55–6.92; P = 0.002). There was a trend toward a reduction in the number of airways containing lymphoid follicles (P = 0.051) in those receiving corticosteroids, with a statistically significant difference between the control and oral ± inhaled corticosteroid–treated groups (P = 0.019). However, corticosteroid treatment had no effect on airway wall thickening or luminal occlusion. Conclusions: Occlusion of the small airways by inflammatory exudates containing mucus is associated with early death in patients with severe emphysema treated by lung volume reduction surgery. Corticosteroid treatment dampens the host immune response in these airways by reducing lymphoid follicles without changing wall thickening and luminal occlusion.Keywords
This publication has 27 references indexed in Scilit:
- Relationship between Pathologic Characteristics of Peripheral Airways and Outcome after Lung Volume Reduction Surgery in Severe Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2006
- Airway and Parenchymal Disease in Chronic Obstructive Pulmonary Disease Are Distinct PhenotypesProceedings of the American Thoracic Society, 2006
- IntroductionProceedings of the American Thoracic Society, 2006
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2002
- Patients at High Risk of Death after Lung-Volume–Reduction SurgeryNew England Journal of Medicine, 2001
- Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polypsJournal of Allergy and Clinical Immunology, 2000
- Pathogenesis of Pneumococcal InfectionNew England Journal of Medicine, 1995
- Elastase Causes Secretory Discharge in Bronchi of Hamsters with Elastase-Induced Secretory Cell MetaplasiaExperimental Lung Research, 1993
- Reassessment of inflammation of airways in chronic bronchitis.BMJ, 1985